Mechanisms linking preterm birth to onset of cardiovascular disease later in adulthood

Area of Science:

• Neonatal research
• Cardiovascular science
• Microbiome research

Background:

• Premature infants exhibit elevated cardiovascular disease (CVD) rates in adulthood.
• The precise mechanisms driving CVD development in this population remain incompletely understood.

Purpose of the Study:

• To review potential pathways contributing to CVD in premature infants.
• To explore novel therapeutic targets for preventing adverse cardiovascular outcomes in preterm neonates.

Main Methods:

• Literature review of studies investigating CVD mechanisms in preterm infants.
• Analysis of factors including oxidative stress, inflammation, lipid profiles, epigenomics, and gut microbiota.
• Examination of emerging research on probiotics, such as Akkermansia muciniphila.

Main Results:

• Preterm neonates experience significant tissue-level oxidant stress and inflammation.
• Alterations in lipid profiles, fetal epigenomics, and gut microbial composition are implicated in CVD development.
• Probiotic interventions, like Akkermansia muciniphila, show promise in reducing inflammation and preventing heart disease in animal models.

Conclusions:

• Identifying and targeting specific pathways early in life is crucial for mitigating the long-term cardiovascular impact of prematurity.
• Interventions aimed at addressing inflammation, oxidative stress, and gut dysbiosis may offer primary and secondary CVD prevention strategies.
• Early intervention holds the potential to improve long-term survival and cardiovascular health in individuals born preterm.